AI Spending Boom Highlights IREN's Execution and Dilution Risks

What happened

A recent Motley Fool article projects AI infrastructure spending to nearly triple to $902 billion by 2029, emphasizing Nvidia's key role and validating the growth narrative for companies like IREN. IREN is aggressively pursuing this opportunity with plans to deploy over 50,000 NVIDIA B300 GPUs through H2 2026, targeting a $3.7 billion AI Cloud annualized run-rate by end-2026. However, the DeepValue report critically notes that IREN's SEC filings still lack GAAP-recognized AI/HPC revenue and detailed contract start dates, making the promised ramp difficult to audit independently. Compounding this, IREN has expanded its at-the-market equity program to $6.0 billion and has already issued over 66 million shares for $1.0 billion, signaling high dilution risk if execution slips. Therefore, despite the optimistic macro backdrop, IREN's stock remains priced on unverified metrics, with the report maintaining a 'WAIT' rating until proof points are met.

Implication

The projected AI spending growth reinforces the market potential but does not address IREN's core vulnerabilities: the absence of auditable AI/HPC revenue in GAAP filings leaves investors unable to verify the buildout's financial impact, increasing reliance on management's non-GAAP claims. With a $6.0B ATM equity program already active, any delays in deploying GPUs or securing contracts could force accelerated share issuance, directly eroding per-share value and capping upside. Monitoring the next 10-Q for AI revenue line items and tracking ATM draw pace against commissioned capacity will be essential to gauge whether dilution is contained. If these proof points are not met within 3-6 months, the bear scenario—with implied value of $22—becomes more likely, driven by financing stress and slippage. Consequently, maintaining a cautious stance aligns with the report's 'WAIT' recommendation, focusing on entry near $24 only after revenue recognition and funding discipline are demonstrated.

Thesis delta

The new article on AI infrastructure spending does not shift the investment thesis for IREN, as it merely echoes the bullish macro trend already priced into the stock. The core thesis remains unchanged: IREN is a 'WAIT' due to unverifiable AI revenue and high dilution risk from its equity ATM. Any delta would only emerge from forthcoming disclosures, such as GAAP AI/HPC revenue recognition or changes in ATM usage relative to deployment milestones.